J&J's (JNJ) Janssen Receives FDA Panel Backing for MDR-TB Drug Bedaquiline
Go back to J&J's (JNJ) Janssen Receives FDA Panel Backing for MDR-TB Drug Bedaquiline| Johnson & Johnson (NYSE: JNJ) | Delayed: 274.29 +3.18 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $271.11 | 52 Week High | $126.07 | |||
| Open | $273.00 | 52 Week Low | $94.28 | |||
| Day High | $276.47 | P/E | 57.02 | |||
| Day Low | $270.56 | EPS | $4.81 | |||
| Volume | 2,336,773 | |||||
